Butz et al. [32] pinpointed miR-124 as a key miRNA contributing to ccRCC aggressiveness by targeting CAV1 and FLOT1 using a miRNA-target network. The gene discussed is FLOT1; the disease is nonpapillary renal cell carcinoma.